FrancophonIA/ELRC3.0 huggingface dataset:
English: Side effects reported with amlodipine or valsartan alone and either not observed with Exforge or observed with a higher frequency than with Exforge:
Slovenian: Neželeni učinki, o katerih so poročali pri uporabi amlodipina ali valsartana samega, ki jih bodisi niso opažali pri uporabi zdravila Exforge ali pa so jih opažali z večjo pogostnostjo kot pri uporabi zdravila Exforge:
English: Excessive hypotension was seen in 0.4% of patients with uncomplicated hypertension treated with Exforge in placebo-controlled studies.
Slovenian: V študijah, kontroliranih s placebom, so čezmerno hipotenzijo opažali pri 0,4 % bolnikov z nezapleteno hipertenzijo, ki so dobivali zdravilo Exforge.
English: Following oral administration of Exforge, peak plasma concentrations of valsartan and amlodipine are reached in 3 and 6-8 hours, respectively.
Slovenian: Po peroralni uporabi zdravila Exforge doseže valsartan največjo koncentracijo v plazmi v 3 urah, amlodipin pa v 6 do 8 urah.
English: Exforge tablets contain two substances called amlodipine and valsartan.
Slovenian: Tablete zdravila Exforge vsebujejo dve učinkovini: amlodipin in valsartan.
English: Over 1,400 hypertensive patients received Exforge once daily in two placebo-controlled trials.
Slovenian: V dveh s placebom kontroliranih preskušanjih je zdravilo Exforge enkrat na dan dobivalo več kot 1.400 bolnikov s hipertenzijo.
English: When switching eligible hypertensive patients (see section 4.1) with hepatic impairment to amlodipine or Exforge, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used.
Slovenian: Pri prehodu ustreznih bolnikov s hipertezijo (glejte poglavje 4.1) z jetrno okvaro na amlodipin ali zdravilo Exforge, je potrebno uporabiti najnižji razpoložljivi odmerek amlodipina v monoterapiji ali kot komponento.
English: Exforge is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.
Slovenian: Zdravilo Exforge je indicirano pri odraslih, pri katerih krvni tlak ni ustrezno urejen ob monoterapiji z amlodipinom ali valsartanom.
English: Exforge is used to treat high blood pressure in adults whose blood pressure is not controlled enough with either amlodipine or valsartan on its own.
Slovenian: Zdravilo Exforge uporabljamo za zdravljenje visokega krvnega tlaka pri odraslih, pri katerih krvni tlak ni dovolj dobro urejen samo z amlodipinom ali samo z valsartanom.
English: ACE inhibitors or aliskiren (see also information under the headings “Do not take Exforge” and “Warnings and precautions”); diuretics (a type of medicine also called “water tablets” which increases the amount of urine you produce); lithium (a medicine used to treat some types of depression); potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium and other substances that may increase potassium levels; certain types of painkillers called non-steroidal anti-inflammatory medicines (NSAIDs) or selective cyclooxygenase-2 inhibitors (COX-2 inhibitors).
Slovenian: To še posebej velja za naslednja zdravila: zaviralci ACE ali aliskiren (glejte tudi informacije pod naslovoma “Ne jemljite zdravila Exforge” in “Opozorila in previdnostni ukrepi”); diuretike (vrsto zdravil, ki jim pravimo tudi "tablete za odvajanje vode" in povečajo nastajanje urina v telesu); litij (zdravilo, ki se uporablja za zdravljenje nekaterih vrst depresij); diuretike, ki varčujejo s kalijem, kalijeve dodatke, nadomestke soli, ki vsebujejo kalij, in druge učinkovine, ki lahko zvišajo koncentracijo kalija; določena zdravila proti bolečinam, ki jih imenujemo nesteroidna protivnetna zdravila (NSAID) ali selektivni zaviralci ciklooksigenaze-2 (zaviralci COX-2).
English: Talk to your doctor before taking Exforge: if you have been sick (vomiting or diarrhoea).
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila Exforge se posvetujte z zdravnikom: če vam je bilo slabo (bruhanje ali driska).
English: There are no clinical studies on fertility with Exforge.
Slovenian: Kliničnih študij glede plodnosti pri uporabi zdravila Exforge ni.
English: When switching eligible elderly hypertensive patients (see section 4.1) to amlodipine or Exforge, the lowest available dose of amlodipine monotherapy or of the amlodipine component, respectively, should be used.
Slovenian: Pri prehodu ustreznih starejših bolnikov s hipertezijo (glejte poglavje 4.1) na amlodipin ali zdravilo Exforge, je potrebno uporabiti najnižji razpoložljivi odmerek amlodipina v monoterapiji ali kot komponento.
English: Exforge should be used with caution to treat hypertension in patients with unilateral or bilateral renal artery stenosis or stenosis to a solitary kidney since blood urea and serum creatinine may increase in such patients.
Slovenian: Pri bolnikih z enostransko ali obojestransko stenozo ledvične arterije oz. s stenozo v primeru solitarne ledvice je pri zdravljenju hipertenzije z zdravilom Exforge potrebna previdnost, saj pri takih bolnikih lahko pride do zvišanja koncentracij sečnine v krvi in kreatinina v serumu.
English: The active substances of Exforge are amlodipine (as amlodipine besylate) and valsartan.
Slovenian: Učinkovini v zdravilu Exforge sta amlodipin (v obliki amlodipinijevega besilata) in valsartan.
English: Hepatic impairment Exforge is contraindicated in patients with severe hepatic impairment (see section 4.3).
Slovenian: Okvara jeter Pri bolnikih s hudo okvaro jeter je zdravilo Exforge kontraindicirano (glejte poglavje 4.3).
English: There is no experience of overdose with Exforge.
Slovenian: Izkušenj s prevelikim odmerjanjem zdravila Exforge ni.
English: No information is available regarding the use of Exforge during breast-feeding, therefore Exforge is not recommended and alternative treatments with better established safety profiles during breast-feeding are preferable, especially while nursing a newborn or preterm infant.
Slovenian: Za uporabo med dojenjem je bolje izbrati drugo zdravilo z dokazanim varnostnim profilom, še posebno če gre za dojenje novorojenčka ali nedonošenčka.
English: Do not use any Exforge pack that is damaged or shows signs of tampering.
Slovenian: Zdravila Exforge ne uporabljajte, če je ovojnina poškodovana ali opazite, da je bila že odprta.
English: Rare (may affect up to 1 in 1,000 people): Feeling anxious; ringing in the ears (tinnitus); fainting; passing more urine than normal or feeling more of an urge to pass urine; inability to get or maintain an erection; sensation of heaviness; low blood pressure with symptoms such as dizziness, light headedness; excessive sweating; skin rash all over your body; itching; muscle spasm.If any of these affect you severely, tell your doctor.
Slovenian: Redki (pojavijo se pri do 1 od 1.000 ljudi): občutek tesnobe; zvonjenje v ušesih (tinitus); omedlevica; izločanje več urina kot ponavadi ali pogostejše siljenje na vodo; nezmožnost za doseganje ali ohranitev erekcije; občutek teže; nizek krvni tlak s simptomi, kot sta omotica in vrtoglavost; čezmerno znojenje; osip po koži po vsem telesu; srbenje; mišični krči.
English: If any of the above applies to you, do not take Exforge and talk to your doctor.
Slovenian: Če kaj od naštetega velja za vas, ne vzemite zdravila Exforge, temveč povejte zdravniku.
English: Exforge 5 mg/80 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg alone.
Slovenian: Zdravilo Exforge 5 mg/80 mg lahko uporabite pri bolnikih, pri katerih krvni tlak ni ustrezno urejen samo s 5 mg amlodipina ali z 80 mg valsartana.
English: No dosage adjustment of Exforge is required for patients with mild to moderate renal impairment (GFR >30 ml/min/1.73 m2).
Slovenian: Pri bolnikih z blago do zmerno okvaro ledvic (GFR >30 ml/min/1,73 m2) odmerka zdravila Exforge ni treba prilagajati.
English: Exforge 10 mg/160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg alone or with Exforge 5 mg/160 mg.
Slovenian: Zdravilo Exforge 10 mg/160 mg lahko uporabite pri bolnikih, pri katerih krvni tlak ni ustrezno urejen samo z 10 mg amlodipina ali s 160 mg valsartana ali s kombinacijo zdravila Exforge 5 mg/160 mg.
English: What Exforge contains
Slovenian: Kaj vsebuje navodilo
English: Exforge 10 mg/160 mg tablets are oval and light yellow with “NVR” on one side and “UIC” on the other side.
Slovenian: Tablete zdravila Exforge 10 mg/160 mg so ovalne in svetlorumene; na eni strani imajo oznako “NVR” in na drugi “UIC”.
English: Exforge 5 mg/80 mg film-coated tablets Exforge 5 mg/160 mg film-coated tablets Exforge 10 mg/160 mg film-coated tablets
Slovenian: Exforge 5 mg/80 mg filmsko obložene tablete Exforge 5 mg/160 mg filmsko obložene tablete Exforge 10 mg/160 mg filmsko obložene tablete
English: Exforge 5 mg/160 mg may be administered in patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg alone.
Slovenian: Zdravilo Exforge 5 mg/160 mg lahko uporabite pri bolnikih, pri katerih krvni tlak ni ustrezno urejen samo s 5 mg amlodipina ali 160 mg valsartana.
English: Exforge 5 mg/80 mg film-coated tablets
Slovenian: Exforge 5 mg/80 mg filmsko obložene tablete
English: Exforge 5 mg/160 mg tablets are oval and dark yellow “NVR” on one side and “ECE” on the other side.
Slovenian: Tablete zdravila Exforge 5 mg/160 mg so ovalne in temnorumene; na eni strani imajo oznako “NVR” in na drugi “ECE”.
English: Exforge 10 mg/160 mg film-coated tablets
Slovenian: Exforge 10 mg/160 mg filmsko obložene tablete
English: Grapefruit and grapefruit juice should not be consumed by people who are taking Exforge.
Slovenian: Ljudje, ki jemljejo zdravilo Exforge, ne smejo uživati grenivk in grenivkinega soka.
English: Exforge 5 mg/80 mg film-coated tablets Exforge 5 mg/160 mg film-coated tablets Exforge 10 mg/160 mg film-coated tablets amlodipine/valsartan
Slovenian: Exforge 5 mg/80 mg filmsko obložene tablete Exforge 5 mg/160 mg filmsko obložene tablete Exforge 10 mg/160 mg filmsko obložene tablete amlodipin/valsartan
English: Hypromellose, substitution type 2910 (3 mPa.s) Titanium dioxide (E171) Iron oxide, yellow (E172) Macrogol 4000
Slovenian: Hipromeloza, substitucijski tip 2910 (3 mPa.s) titanov dioksid (E171) rumeni železov oksid (E172) makrogol 4000 smukec
English: Exforge 10 mg/160 mg film-coated tablets amlodipine/valsartan
Slovenian: Exforge 10 mg/160 mg filmsko obložene tablete amlodipin/valsartan
English: Exforge should be discontinued immediately in patients who develop angioedema and should not be re-administered.
Slovenian: Bolnikom, pri katerih pride do angioedema, je treba zdravilo Exforge takoj ukiniti.
English: Exforge 5 mg/160 mg film-coated tablets
Slovenian: Exforge 5 mg/160 mg filmsko obložene tablete
English: EU/1/06/370/035 280 film-coated tablets (4x70) EU/1/06/370/038 280 film-coated tablets (20x14)
Slovenian: EU/1/06/370/035 280 filmsko obloženih tablet (4x70) EU/1/06/370/038 280 filmsko obloženih tablet (20x14)
English: What Exforge looks like and contents of the pack Exforge 5 mg/80 mg tablets are round and dark yellow with “NVR” on one side and “NV” on the other side.
Slovenian: Tablete zdravila Exforge 5 mg/80 mg so okrogle in temnorumene; na eni strani imajo oznako “NVR” in na drugi “NV”.
English: EU/1/06/370/036 280 film-coated tablets (4x70) EU/1/06/370/039 280 film-coated tablets (20x14)
Slovenian: EU/1/06/370/036 280 filmsko obloženih tablet (4x70) EU/1/06/370/039 280 filmsko obloženih tablet (20x14)
English: EU/1/06/370/034 280 film-coated tablets (4x70) EU/1/06/370/037 280 film-coated tablets (20x14)
Slovenian: EU/1/06/370/034 280 filmsko obloženih tablet (4x70) EU/1/06/370/037 280 filmsko obloženih tablet (20x14)
English: Exforge 5 mg/80 mg film-coated tablets amlodipine/valsartan
Slovenian: Exforge 5 mg/80 mg filmsko obložene tablete amlodipin/valsartan
English: How to store Exforge
Slovenian: Shranjevanje zdravila Exforge
English: Exforge 5 mg/160 mg film-coated tablets amlodipine/valsartan
Slovenian: Exforge 5 mg/160 mg filmsko obložene tablete amlodipin/valsartan
English: * Mostly consistent with cholestasis
Slovenian: * o tem so najpogosteje poročali v povezavi s holestazo Dodatne informacije o kombinaciji
English: EU/1/06/370/001 7 film-coated tablets EU/1/06/370/002 14 film-coated tablets EU/1/06/370/003 28 film-coated tablets EU/1/06/370/004 30 film-coated tablets EU/1/06/370/005 56 film-coated tablets EU/1/06/370/006 90 film-coated tablets EU/1/06/370/007 98 film-coated tablets EU/1/06/370/008 280 film-coated tablets EU/1/06/370/025 56x1 film-coated tablet (unit dose) EU/1/06/370/026 98x1 film-coated tablet (unit dose) EU/1/06/370/027 280x1 film-coated tablet (unit dose)
Slovenian: EU/1/06/370/001 7 filmsko obloženih tablet EU/1/06/370/002 14 filmsko obloženih tablet EU/1/06/370/003 28 filmsko obloženih tablet EU/1/06/370/004 30 filmsko obloženih tablet EU/1/06/370/005 56 filmsko obloženih tablet EU/1/06/370/006 90 filmsko obloženih tablet EU/1/06/370/007 98 filmsko obloženih tablet EU/1/06/370/008 280 filmsko obloženih tablet EU/1/06/370/025 56x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/026 98x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/027 280x1 filmsko obložena tableta (za enkratni odmerek)
English: Myalgia
Slovenian: Obloga
English: EU/1/06/370/017 7 film-coated tablets EU/1/06/370/018 14 film-coated tablets EU/1/06/370/019 28 film-coated tablets EU/1/06/370/020 30 film-coated tablets EU/1/06/370/021 56 film-coated tablets EU/1/06/370/022 90 film-coated tablets EU/1/06/370/023 98 film-coated tablets EU/1/06/370/024 280 film-coated tablets EU/1/06/370/031 56x1 film-coated tablet (unit dose) EU/1/06/370/032 98x1 film-coated tablet (unit dose) EU/1/06/370/033 280x1 film-coated tablet (unit dose)
Slovenian: EU/1/06/370/017 7 filmsko obloženih tablet EU/1/06/370/018 14 filmsko obloženih tablet EU/1/06/370/019 28 filmsko obloženih tablet EU/1/06/370/020 30 filmsko obloženih tablet EU/1/06/370/021 56 filmsko obloženih tablet EU/1/06/370/022 90 filmsko obloženih tablet EU/1/06/370/023 98 filmsko obloženih tablet EU/1/06/370/024 280 filmsko obloženih tablet EU/1/06/370/031 56x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/032 98x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/033 280x1 filmsko obložena tableta (za enkratni odmerek)
English: EU/1/06/370/009 7 film-coated tablets EU/1/06/370/010 14 film-coated tablets EU/1/06/370/011 28 film-coated tablets EU/1/06/370/012 30 film-coated tablets EU/1/06/370/013 56 film-coated tablets EU/1/06/370/014 90 film-coated tablets EU/1/06/370/015 98 film-coated tablets EU/1/06/370/016 280 film-coated tablets EU/1/06/370/028 56x1 film-coated tablet (unit dose) EU/1/06/370/029 98x1 film-coated tablet (unit dose) EU/1/06/370/030 280x1 film-coated tablet (unit dose)
Slovenian: EU/1/06/370/009 7 filmsko obloženih tablet EU/1/06/370/010 14 filmsko obloženih tablet EU/1/06/370/011 28 filmsko obloženih tablet EU/1/06/370/012 30 filmsko obloženih tablet EU/1/06/370/013 56 filmsko obloženih tablet EU/1/06/370/014 90 filmsko obloženih tablet EU/1/06/370/015 98 filmsko obloženih tablet EU/1/06/370/016 280 filmsko obloženih tablet EU/1/06/370/028 56x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/029 98x1 filmsko obložena tableta (za enkratni odmerek) EU/1/06/370/030 280x1 filmsko obložena tableta (za enkratni odmerek)
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING
Slovenian: Izgled zdravila Exforge in vsebina pakiranja
English: If any of the following happen, tell your doctor straight away:
Slovenian: Če se karkoli od naštetega pri vas pojavi v hudi obliki, morate to povedati zdravniku.
English: This summary was last updated in 02-2012.
Slovenian: Povzetek je bil nazadnje posodobljen 01-2016.
English: The full EPAR for Clopidogrel Acino can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Klopidogrel Acino je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: • patients who have recently had a myocardial infarction (heart attack).
Slovenian: • ki so nedavno doživeli miokardni infarkt (srčni napad).
English: For more information about treatment with Clopidogrel Acino, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Klopidogrel Acino preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: This is a summary of the European public assessment report (EPAR) for Clopidogrel Acino.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Klopidogrel Acino.
English: This means that Clopidogrel Acino is similar to a ‘reference medicine' already authorised in the European Union (EU) called Plavix.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Plavix.
English: • patients with peripheral arterial disease (problems with blood flow in the arteries);
Slovenian: • ki imajo periferno arterijsko bolezen (težave s pretokom krvi v arterijah);
English: The European Commission granted a marketing authorisation valid throughout the EU for Clopidogrel Acino on 28 July 2009.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Klopidogrel Acino, veljavno po vsej Evropski uniji, izdala 28. julija 2009.
English: This is then followed by the standard 75 mg dose once a day for at least four weeks (in ST segment elevation myocardial infarction) or for up to 12 months (in non-ST segment elevation syndrome).
Slovenian: Temu sledi običajni 75-miligramski odmerek enkrat na dan najmanj štiri tedne (pri miokardnem infarktu z dvigom spojnice ST) ali največ 12 mesecev (pri nestabilni angini pektoris ali miokardnem infarktu brez zobca Q).
English: The standard dose of Clopidogrel Acino is one 75 mg tablet once a day.
Slovenian: Običajni odmerek zdravila Klopidogrel Acino je ena 75-miligramska tableta enkrat na dan.
English: EPAR summary for the public clopidogrel
Slovenian: Povzetek EPAR za javnost
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Clopidogrel Acino.
Slovenian: Pojasnjuje, kako je Odbor za zdravila za uporabo v humani medicini (CHMP) ocenil to zdravilo, na podlagi česar je oblikoval mnenje za izdajo dovoljenja za promet z njim in priporočila glede pogojev njegove uporabe.
English: What are the benefits and risks of Clopidogrel Acino?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Klopidogrel Acino?
English: Clopidogrel Acino can be started between a few days and 35 days after the attack;
Slovenian: Zdravilo Klopidogrel Acino se lahko začne jemati od nekaj dni po napadu do 35 dni po njem;
English: Because Clopidogrel Acino is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as those of the reference medicine.
Slovenian: Ker je zdravilo Klopidogrel Acino generično zdravilo in je biološko enakovredno referenčnemu zdravilu, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: The Committee recommended that Clopidogrel Acino be given marketing authorisation.
Slovenian: Odbor je zato priporočil, da se za zdravilo Klopidogrel Acino izda dovoljenje za promet.
English: Other information about Clopidogrel Acino
Slovenian: Druge informacije o zdravilu Klopidogrel Acino
English: Clopidogrel Acino is a ‘generic medicine'.
Slovenian: Klopidogrel Acino je „generično zdravilo“.
English: The CHMP concluded that, in accordance with EU requirements, Clopidogrel Acino has been shown to have comparable quality and to be bioequivalent to Plavix.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Klopidogrel Acino primerljivo raven kakovosti kot zdravilo Plavix ter da mu je biološko enakovredno.
English: Clopidogrel Acino can be started between seven days and six months after the stroke;
Slovenian: Zdravilo Klopidogrel Acino se lahko začne jemati od sedem dni po napadu in do šest mesecev po njem;
English: • patients who have had a recent ischaemic stroke (stroke caused by failure of the blood supply to part of the brain).
Slovenian: • ki so nedavno utrpeli ishemično kap (kap zaradi neoskrbe določenega dela možganov s krvjo).
English: Because Clopidogrel Acino is a generic medicine, studies have been limited to tests to determine that it is bioequivalent to the reference medicine, Plavix.
Slovenian: Ker je zdravilo Klopidogrel Acino generično zdravilo, so bile študije pri ljudeh omejene na preskuse za ugotavljanje, ali je biološko enakovredno referenčnemu zdravilu Plavix.
English: In acute coronary syndrome, Clopidogrel Acino is used together with aspirin and treatment generally starts with a loading dose of four 75 mg tablets.
Slovenian: Pri akutnem koronarnem sindromu se zdravljenje na splošno začne z udarnim odmerkom štirih 75-miligramskih tablet.
English: Therefore, the CHMP's view was that, as for Plavix, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da njegove koristi enako kot pri zdravilu Plavix odtehtajo znana tveganja.
English: Clopidogrel Acino is used in adults to prevent atherothrombotic events (problems caused by blood clots and hardening of the arteries).
Slovenian: Zdravilo Klopidogrel Acino se uporablja za preprečevanje težav, ki jih povzročajo krvni strdki pri odraslih:
English: Clopidogrel Acino is a medicine that contains the active substance clopidogrel.
Slovenian: Klopidogrel Acino je zdravilo, ki vsebuje zdravilno učinkovino klopidogrel.
English: The active substance in Clopidogrel Acino, clopidogrel, is an inhibitor of platelet aggregation.
Slovenian: Zdravilna učinkovina zdravila Klopidogrel Acino, klopidogrel, je zaviralec agregacije trombocitov.
English: • patients who have a condition known as ‘acute coronary syndrome', when it should be given with aspirin (another medicine that prevents blood clots), including patients who have had a stent inserted (a short tube placed in an artery to prevent it closing up).
Slovenian: • ki imajo akutni koronarni sindrom, pri katerem se mora zdravilo dajati skupaj z aspirinom (drugim zdravilom za preprečevanje krvnih strdkov).
English: Why has Clopidogrel Acino been approved?
Slovenian: Zakaj je bilo zdravilo Klopidogrel Acino odobreno?
English: How has Clopidogrel Acino been studied?
Slovenian: Kako je bilo zdravilo Klopidogrel Acino raziskano?
English: How does Clopidogrel Acino work?
Slovenian: Kako zdravilo Klopidogrel Acino deluje?
English: What is Clopidogrel Acino used for?
Slovenian: Za kaj se zdravilo Klopidogrel Acino uporablja?
English: What is Clopidogrel Acino?
Slovenian: Kaj je zdravilo Klopidogrel Acino?
English: How is Clopidogrel Acino used?
Slovenian: Kako se zdravilo Klopidogrel Acino uporablja?
English: It can also be used in patients who do not have this abnormal reading on the ECG, if they have unstable angina (a severe type of chest pain) or have had a ‘non-Q-wave' myocardial infarction.
Slovenian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom zajema tudi srčni napad in nestabilno angino pektoris (hudo obliko bolečine v prsih).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Cholib on 26 August 2013.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Cholib, veljavno po vsej Evropski uniji, odobrila 26. avgusta 2013.
English: The recommended dose is one tablet a day to be swallowed whole with a glass of water.
Slovenian: Priporočeni odmerek je ena tableta na dan, ki jo je treba pogoltniti celo s kozarcem vode.